%0 Journal Article
%T Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) study protocol: a prospective observational cohort study of reproductive-aged women living with HIV.
%A Kacanek D
%A Yee LM
%A Yao TJ
%A Lee J
%A Chadwick EG
%A Williams PL
%A Barr EA
%A Berman CA
%A Davtyan M
%A DiPerna A
%A Flores A
%A Green J
%A Haddad LB
%A Hyzy L
%A Jacobson DL
%A James-Todd T
%A Jao J
%A Khadraoui A
%A Malee KM
%A Moscicki AB
%A Patel K
%A Robinson LG
%A Salomon L
%A Sanders K
%A Siminski S
%A Smith RA
%A Wolbach T
%A Powis KM
%A  
%A  
%J BMJ Open
%V 14
%N 7
%D 2024 Jul 5
%M 38969382
%F 3.006
%R 10.1136/bmjopen-2024-084835
%X <B>BACKGROUND: </B>Over 265 000 women are living with HIV in the USA, but limited research has investigated the physical, mental and behavioural health outcomes among women living with HIV of reproductive age. Health status during the reproductive years before, during and after pregnancy affects pregnancy outcomes and long-term health. Understanding health outcomes among women living with HIV of reproductive age is of substantial public health importance, regardless of whether they experience pregnancy. The Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) study is a prospective observational cohort study designed to investigate physical and mental health outcomes of young women living with HIV as they age, including HIV disease course, engagement in care, reproductive health and choices and cardiometabolic health. We describe the HOPE study design, and characteristics of the first 437 participants enrolled as of 1 January 2024.<BR><B>METHODS: </B>The HOPE study seeks to enrol and follow 1630 women living with HIV of reproductive age, including those with perinatally-acquired HIV, at 12 clinical sites across 9 US states and Puerto Rico. HOPE studies multilevel dynamic determinants influencing physical, mental and social well-being and behaviours of women living with HIV across the reproductive life course (preconception, pregnancy, post partum, not or never-pregnant), informed by the socioecological model. Key research areas include the clinical course of HIV, relationship of HIV and antiretroviral medications to reproductive health, pregnancy outcomes and comorbidities and the influence of racism and social determinants of health. HOPE began enrolling in April 2022.<BR><B>BACKGROUND: </B>The HOPE study received approval from the Harvard Longwood Campus Institutional Review Board, the single institutional review board of record for all HOPE sites. Results will be disseminated through conference presentations, peer-reviewed journals and lay summaries.